Bridgefront Capital’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Sell
43,826
-50,430
-54% -$334K 0.07% 407
2026
Q1
$488K Buy
94,256
+15,483
+20% +$96.9K 0.12% 284
2025
Q4
$576K Buy
78,773
+62,649
+389% +$607K 0.14% 234
2025
Q3
$161K Buy
16,124
+667
+4% +$7.38K 0.05% 536
2025
Q2
$140K Sell
15,457
-47,557
-75% -$310K 0.04% 565
2025
Q1
$405K Buy
63,014
+9,748
+18% +$86.8K 0.12% 317
2024
Q4
$507K Buy
+53,266
New +$468K 0.17% 203
2024
Q2
Sell
-22,816
Closed -$160K 532
2024
Q1
$160K Buy
+22,816
New +$198K 0.12% 330

Other funds holding ENVX

Bridgefront Capital's ENVX Position: Q2 2026 in Review

Bridgefront Capital reduced its Enovix (ENVX) stake by 54% in Q2 2026, selling an estimated $334K and leaving 43,826 shares worth $266K. The position accounts for 0.07% of the portfolio, ranked #407.

Bridgefront Capital first reported a position in ENVX in Q1 2024 and has held it in 8 quarters since. The position peaked at $576K in Q4 2025. 298 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • Bridgefront Capital held 43,826 shares of Enovix worth $266K as of Q2 2026.
  • Bridgefront Capital sold 50,430 Enovix shares in Q2 2026, an estimated $334K.
  • Enovix made up 0.07% of Bridgefront Capital's portfolio in Q2 2026, its #407 holding.
  • Bridgefront Capital first reported a position in Enovix in Q1 2024 and has held it in 8 quarters since.
  • Bridgefront Capital's Enovix position peaked at $576K in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.